Evidence map›Paper›PMID 38712152›Full record

ArticlebioRxiv : the preprint server for biology2024

Stochastic modelling of single-cell gene expression adaptation reveals non-genomic contribution to evolution of tumor subclones.

M G Hirsch, Soumitra Pal, Farid Rashidi Mehrabadi, Salem Malikic, Charli Gruen, Antonella Sassano, Eva Pérez-Guijarro, Glenn Merlino, Cenk Sahinalp, Erin K Molloy and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

M G HirschNational Library of Medicine, NIH, Bethesda, Maryland, USA.
Soumitra PalNeurobiology Neurodegeneration and Repair Lab, National Eye Institute, NIH, Bethesda, Maryland, USA.
Farid Rashidi MehrabadiCancer Data Science Laboratory, Center for Cancer Research, National Cancer institute, NIH, Bethesda, Maryland, USA.
Salem MalikicCancer Data Science Laboratory, Center for Cancer Research, National Cancer institute, NIH, Bethesda, Maryland, USA.
Charli GruenLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Antonella SassanoLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Eva Pérez-GuijarroLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Glenn MerlinoLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Cenk SahinalpCancer Data Science Laboratory, Center for Cancer Research, National Cancer institute, NIH, Bethesda, Maryland, USA.
Erin K MolloyDepartment of Computer Science, University of Maryland, College Park, Maryland USA.ORCID 0000-0001-5553-3312
Chi-Ping DayLaboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Teresa M PrzytyckaNational Library of Medicine, NIH, Bethesda, Maryland, USA.

Funding

Genetically Engineered Mouse Models to Study RTK Function in MelanomaZIABC008756 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MERLINO, GLENN T. · 2009 to 2024
$17.7M
6 · The paper itself

Abstract

Cancer progression is an evolutionary process driven by the selection of cells adapted to gain growth advantage. We present the first formal study on the adaptation of gene expression in subclonal evolution. We model evolutionary changes in gene expression as stochastic Ornstein-Uhlenbeck processes, jointly leveraging the evolutionary history of subclones and single-cell expression data. Applying our model to sublines derived from single cells of a mouse melanoma revealed that sublines with distinct phenotypes are underlined by different patterns of gene expression adaptation, indicating non-genetic mechanisms of cancer evolution. Interestingly, sublines previously observed to be resistant to anti-CTLA-4 treatment showed adaptive expression of genes related to invasion and non-canonical Wnt signaling, whereas sublines that responded to treatment showed adaptive expression of genes related to proliferation and canonical Wnt signaling. Our results suggest that clonal phenotypes emerge as the result of specific adaptivity patterns of gene expression.

Indexed as

adaptationclonal evolutiongene expressionimmunotherapy responsemelanomaOrnstein-Uhlenbeck processessingle-cell analysisWNT signaling

Identifiers

PMID38712152
PMCPMC11071284

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.